| Financial Year |
March 31 2023 |
| Monetary Funds |
4,855,693,005.00 |
| Held-for-trading Financial Assets |
67,790,695.71 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,698,602,179.22 |
| Advances to Suppliers |
2,972,705,868.66 |
| Other Receivables |
330,780,537.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
24,682,878.00 |
| Inventories |
796,612,258.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
562,728,249.43 |
| Total Current Assets |
13,347,808,897.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,000,000.00 |
| Long-term Equity Investment |
5,417,150,714.16 |
| Investment Properties |
277,556,101.46 |
| Fixed Assetes |
47,898,826,915.35 |
| Under-construction Projects |
8,750,884,999.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,675,062,625.97 |
| R&D expenses |
7,537,658.47 |
| Goodwill |
906,860,215.02 |
| Long-Term Deferred and Prepaid Expenses |
28,508,468.15 |
| Deferred Income Tax Assets |
882,276,439.08 |
| Other Non-Current Assets |
1,549,053,174.73 |
| Sub-Total of Non-Current Assets |
68,346,016,938.97 |
| Total Assets |
81,693,825,836.15 |
| Short-Term Loans |
2,148,673,873.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,751,040,671.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
126,771,872.94 |
| Taxes Payable |
165,805,596.56 |
| Interest Payable |
-- |
| Dividend Payable |
5,496,810.40 |
| Other payables |
1,201,978,526.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,793,074,668.42 |
| Other Current Liabilities |
652,227,033.52 |
| Sub-Total of Current Liabilities |
14,036,868,276.41 |
| Long-term Loans |
24,733,721,932.34 |
| Bonds Payable |
3,470,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,727,055.25 |
| Deferred Income Tax Liabilities |
1,346,978,150.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,486,192,106.80 |
| Total Liabilities |
44,523,060,383.21 |
| Paid-In Capital(Or Share Stock) |
6,568,972,986.00 |
| Capital Surplus |
10,764,712,149.19 |
| Surplus Reserve |
1,506,348,614.86 |
| LESS:Treasury Stock |
249,224,442.14 |
| Undistributed Profits |
12,239,826,018.49 |
| Minority Stockholder's Interest |
6,147,298,559.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
31,023,466,893.01 |
| Owner's Equity（Stockholder's Equity） |
37,170,765,452.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
81,693,825,836.15 |
